On April 28, 2008, drug manufacturers Actavis Totowa LLC issued a Class I nationwide recall of all Digitek® digoxin tablets distributed between March 2006 and April 2008. The pills may contain two times the acceptable dosage of the active ingredient.
Class I recalls are conducted when
DANGEROUS or
DEFECTIVE products that predictably could cause serious health problems or death are released.
Digitek® tablets are prescribed for treatment of heart failure and abnormal heart rhythms. The existence of double strength tablets poses a risk of digitalis toxicity. This could lead to serious and potentially fatal illness caused by overmedication, especially among individuals with renal insufficiencies.
Digitalis toxicity can cause among other things:
- Death or hospitalization
- Visual changes, changes in color perception -yellow-green distortion is most common, but red, brown, blue, and white also occur, halos, bright spots, blind spots, blurred vision
- Palpitations
- Irregular pulse, bradycardia (slow heart rate below 60 bpm)
- Dizziness, loss of consciousness
- Low blood pressure
- Loss of appetite
- Nausea/ vomiting
- Decreased urine output
- Excessive nighttime urination
- Cold sweats
- Difficulty breathing when lying down
If you believe that you or a loved one has suffered hospitalization or death as a result of taking Digitek®, fill out our online form or call us toll free at
1-866-828-4699.
www.digitekrecallinformation.com
